Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

531
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
531
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

33
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
33
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

68
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
68
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

206
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
206
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

76
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
76

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Population Pharmacokinetics and Exposure-Response Model-Based Bayesian Extrapolation of FVC-Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.

Pharmaceutics·2025
Same author

Bounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357.

CPT: pharmacometrics & systems pharmacology·2023
Same author

AB-stacked nanosheet-based hexagonal boron nitride.

Acta crystallographica Section B, Structural science, crystal engineering and materials·2021
Same author

Parametric Time-to-Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis.

CPT: pharmacometrics & systems pharmacology·2020

相关实验视频

Updated: May 21, 2025

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

17.4K

少是多:对交互式药量计工具的设计考虑-使用模型可视化平台 (MVP) 应用程序的案例研究.

Steve Choy1, Jin Gyu Kim2, Julia Korell3

  • 1Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.

CPT: pharmacometrics & systems pharmacology
|March 20, 2025
PubMed
概括

药量测量科学家使用R Shiny应用程序进行交互工具. 本研究探讨了用户界面和用户体验设计,以改进这些复杂的,类似平台的应用程序,以实现更好的参与.

更多相关视频

Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.5K
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.1K

相关实验视频

Last Updated: May 21, 2025

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

17.4K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

9.5K
Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
10:44

Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline

Published on: December 7, 2021

2.1K

科学领域:

  • 制药指标 (Pharmacometrics) 是一个指标.
  • 计算科学 计算科学
  • 数据可视化 数据可视化

背景情况:

  • R Shiny 软件包有助于创建用于药量测量 (PMX) 的交互式 Web 应用程序.
  • 最初是为项目特定的模拟开发的,Shiny应用已经演变为更通用的,类似平台的工具.
  • 闪亮应用程序日益复杂,需要专注于以用户为中心的设计.

研究的目的:

  • 为了调查在药物测量中对用户界面 (UI) 和用户体验 (UX) 的未开发的设计考虑因素.
  • 为优化最终用户互动性和享受复杂的基于R的工具提供见解.

主要方法:

  • 对现有的Shiny应用程序开发在药理学中的文献综述.
  • 分析科学软件中常见的UI/UX模式.
  • 关于成功和不太成功的Shiny应用程序实现的案例研究 (详细信息不在摘要中提供).

主要成果:

  • 在当前的药物测量中确定了关键的UI/UX挑战.
  • 突出了应用程序功能和用户友好性之间的差距.
  • 强调在科学工具开发中需要系统的UI/UX设计原则.

结论:

  • 优化用户界面/用户体验对于有效采用和利用药物测量应用至关重要.
  • 未来的开发应该优先考虑以用户为中心的设计,以增强交互性和参与度.
  • 需要进行进一步的研究,以建立 Shiny app UI/UX 在科学领域的最佳实践.